Transforming growth factor-β induces collagen synthesis without inducing IL-8 production in mesothelial cells

European Respiratory Journal

Volumn 22, Issue 2, 2003, Pages 197-202

  Lee, Y C Gary ^a,b,c   Lane, K B ^a   Zoia, O ^a   Thompson, P J ^c   Light, R W ^a,b   Blackwell, T S ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b SAINT THOMAS HOSPITAL   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Fibrosis; Interleukin 8; Mesothelial; Pleura; Transforming growth factor

Indexed keywords

COLLAGEN; DOXYCYCLINE; INTERLEUKIN 8; LACTATE DEHYDROGENASE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TALC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; MESOTHELIUM CELL; NONHUMAN; PLEURA FLUID; PLEURAL FIBROSIS; PLEURISY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; EPITHELIAL CELLS; INJECTIONS; INTERLEUKIN-8; PLEURA; RABBITS; TALC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0042026804     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00086202     Document Type: Article

References (35)

1. Lee YCG, Rodriguez RM, Lane KB, Light RW. Pleurodesis for recurrent pleural effusions in the new millenium. Recent Adv Res Updates 2001; 2: 81-89.
2. Light RW. Pleural Diseases. Baltimore, Lippincott, Williams & Wilkins, 2001.
3. Lee YCG, Lane KB. Cytokines in pleural diseases. In: Light RW, Lee YCG, eds. Textbook of Pleural Diseases. London, Arnold Press, 2003; pp. 63-89.
4. van den Heuvel MM, Smit HJ, Barbierato SB, Havenith CE, Beelen RH, Postmus PE. Talc-induced inflammation in the pleural cavity. Eur Respir J 1998; 12: 1419-1423.
5. Miller EJ, Kajikawa O, Pueblitz S, Light RW, Koenig KK, Idell S. Chemokine involvement in tetracycline-induced pleuritis. Eur Respir J 1999; 14: 1387-1393.
6. Utsunomiya I, Ito M, Watanabe K, Tsurufuji S, Matsushima K, Oh S. Infiltration of neutropbils by intrapleural injection of tumour necrosis factor, interleukin-1, and interleukin-8 in rats, and its modification by actinomycin D. Br J Pharmacol 1996; 117: 611-614.
7. Xie C, Teixeira LR, McGovern JP, Light RW. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med 1998; 157: 1441-1444.
8. Teixeira LR, Wu W, Cheng DS, Light RW. The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits. Chest 2002; 121: 216-219.
9. Border W, Noble NA. Transforming growth factor-beta in tissue fibrosis. New Engl J Med 1994; 331: 1286-1292.
10. Lee YCG, Lane KB. The many faces of transforming growth factor beta in pleural diseases. Curr Opin Pulm Med 2001; 7: 173-179.
11. 2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 2001; 163: 640-644.
12. Light RW, Cheng DS, Lee YCG, Rogers J, Davidson J, Lane KB. A single intrapleural injection of transforming growth factor beta-2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000; 162: 98-104.
13. 2) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000; 55: 1058-1062.
14. 2, talc and bleomycin as pleurodesing agents in sheep. Respirology 2002; 7: 209-216.
15. Sheppard D. Pulmonary fibrosis: a cellular overreaction or a failure of communication? J Clin Invest 2001; 107: 1501-1502.
16. Gauldie J. Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165: 1205-1206.
17. Nasreen N, Hartman DL, Mohammed KA, Antony VB. Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells. Am J Respir Crit Care Med 1998; 158: 971-978.
18. Ogawa Y, Seyedin SM. Purification of transforming growth factor beta 1 and beta 2 from bovine and cell culture assays. Methods Enzymol 1991; 198: 317-327.
19. Lee YCG, Malkerneker D, Thompson PJ, Light RW, Lane KB. Transforming growth factor-β induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med 2002; 165: 88-94.
20. Lee YCG, Devin CJ, Teixiera LR, et al. Transforming growth factor beta-2 induced pleurodesis is not inhibited by corticosteroids. Thorax 2001; 56: 643-648.
21. Strieter RM. Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165: 1206-1207.
22. Kobe M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1b induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001; 107: 1529-1536.
23. Kennedy L, Harley RA, Sahn SA, Strange C. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest 1995; 107: 1707-1712.
24. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413.
25. Segura RM, Alegre J, Varela E, et al. Interleukin-8 and markers of neutrophil degranulation in pleural effusions. Am J Respir Crit Care Med 1998; 157: 1565-1572.
26. Ceyhan BB, Ozgun S, Celikel T, Yalcin M, Koc M. IL-8 in pleural effusion. Respir Med 1996; 90: 215-221.
27. Antony VB, Godbey SW, Kunkel SL, et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993; 151: 7216-7223.
28. Boylan AM, Hebert CA, Sadick M, et al. Interleukin-8 is a major component of pleural liquid chemotactic activity in a rabbit model of endotoxin pleurisy. Am J Physiol 1994; 267: L137-L144.
29. Stam TC, Swaak AJ, Kruit WH, Stoter G, Eggermont AM. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response. Eur J Clin Invest 2000; 30: 336-343.
30. Antony VB, Holt JW, Kunkel SL, Godbey SW, Burdick MD, Strieter RM. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am J Respir Cell Mol Biol 1995; 12: 581-588.
31. Kumar NM, Rabadi NH, Sigurdson LS, Schunemann HJ, Lwebuga-Mukasa JS. Induction of interleukin-1 and interleukin-8 mRNAs and proteins by TGF beta 1 in rat lung alveolar epithelial cells. J Cell Physiol 1996; 169: 186-199.
32. Winkler M, Rath W, Fischer DC, van de Leur E, Haubeck H. Regulation of interleukin-8 synthesis in human lower uterine segment fibroblasts by cytokines and growth factors. Obstet Gynecol 2000; 95: 584-588.
33. Mao JT, Zhu LX, Sharma S, et al. Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta. Cell Immunol 1997; 181: 38-43.
34. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996; 2: 40-45.
35. Gutman M, Singh RK, Xie K, Bucana CD, Fidler IJ. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995; 55: 2470-2475.